INFUSYSTEM HOLDINGS, INC Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- INFUSYSTEM HOLDINGS, INC treasury stock, value, acquired, cost method for the quarter ending 2018-06-30 was $1.18M.
- INFUSYSTEM HOLDINGS, INC treasury stock, value, acquired, cost method for the quarter ending 2018-03-31 was $83.00K.
- INFUSYSTEM HOLDINGS, INC treasury stock, value, acquired, cost method for fiscal 2018 was $10.39M.
- INFUSYSTEM HOLDINGS, INC treasury stock, value, acquired, cost method for fiscal 2011 was $331.00K, a 190.35% increase from fiscal 2010.
- INFUSYSTEM HOLDINGS, INC treasury stock, value, acquired, cost method for fiscal 2010 was $114.00K.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2018-12-31 | $10.39M 10-K · filed 2019-03-22 | |
| 2018-06-30 | $1.18M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $83.00K 10-Q · filed 2019-05-15 | |
| 2011-12-31 | $331.00K 10-K · filed 2013-03-28 | |
| 2010-12-31 | $114.00K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |